Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts

Karl Mårild,Tereza Lerchova,Malin Östensson,Henrik Imberg,Ketil Størdal,Johnny Ludvigsson
DOI: https://doi.org/10.1111/apt.18358
IF: 9.524
2024-10-27
Alimentary Pharmacology & Therapeutics
Abstract:This Scandinavian binational cohort study found that early‐life antibiotic use was associated with IBD development in childhood or young adulthood, independent of early‐life infection frequency. Infection frequency itself was not a major risk factor. Our findings suggest that antibiotics, rather than infection frequency, may influence IBD risk. Background Childhood antibiotic use has been associated with inflammatory bowel disease (IBD), although the potential contribution of infection frequency remains uncertain. Aims To explore the association between early‐life infections, antibiotics and IBD development. Methods We used population‐based data from ABIS (Sweden) and MoBa (Norway) cohorts following children from birth (1997–2009) until 2021. Prospectively collected questionnaires identified infection frequency (any, gastrointestinal and respiratory) and antibiotics (any, penicillin and non‐penicillin) until age 3. IBD diagnosis required ≥ 2 records in national health registries. Cohort‐specific hazard ratios (aHR), adjusted for parental education, smoking and IBD were estimated and pooled using a random‐effects model. Antibiotic analyses were adjusted for infection frequency. Results There were 103,046 children (11,872 ABIS and 91,174 MoBa), contributing to 1,663,898 person‐years of follow‐up, during which 395 were diagnosed with IBD. The frequency of any infection at 0 to
pharmacology & pharmacy,gastroenterology & hepatology
What problem does this paper attempt to address?